We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-6.62%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$159M
AUM Growth
-$13M
Cap. Flow
-$34.8K
Cap. Flow %
-0.02%
Top 10 Hldgs %
22.04%
Holding
189
New
40
Increased
46
Reduced
55
Closed
32

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$1.24M
2
ARW icon
Arrow Electronics
ARW
+$1.12M
3
IDXX icon
Idexx Laboratories
IDXX
+$918K
4
ROL icon
Rollins
ROL
+$908K
5
DHR icon
Danaher
DHR
+$906K

Top Sells

Rank Stock Value
1
LNG icon
Cheniere Energy
LNG
+$2.66M
2
WMT icon
Walmart Inc
WMT
+$2.1M
3
CHRW icon
C.H. Robinson
CHRW
+$1.39M
4
ABT icon
Abbott
ABT
+$1.31M
5
AME icon
Ametek
AME
+$1.26M

Sector Composition

Rank Sector Weight
1 Industrials 21.35%
2 Healthcare 19.44%
3 Financials 12.65%
4 Consumer Staples 12.28%
5 Technology 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
101
Eli Lilly
LLY
$1.01T
$483K 0.3%
1,495
+210
+16% +$66.5K
PNR icon
102
Pentair
PNR
$9.03B
$480K 0.3%
+11,825
New +$548K
EQT icon
103
EQT Corp
EQT
$33.2B
$478K 0.3%
11,725
-1,100
-9% -$47.7K
OGN icon
104
Organon & Co
OGN
$3.59B
$462K 0.29%
+19,729
New +$596K
J icon
105
Jacobs Solutions
J
$17B
$461K 0.29%
+5,138
New +$532K
OVV icon
106
Ovintiv
OVV
$18.5B
$458K 0.29%
+9,950
New +$475K
GD icon
107
General Dynamics
GD
$97B
$446K 0.28%
2,104
+1,152
+121% +$260K
MRVL icon
108
Marvell Technology
MRVL
$199B
$443K 0.28%
10,315
-7,797
-43% -$386K
V icon
109
Visa
V
$701B
$425K 0.27%
2,390
+925
+63% +$188K
AQUA
110
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$415K 0.26%
+12,550
New +$456K
ENS icon
111
EnerSys
ENS
$6.15B
$404K 0.25%
+6,953
New +$443K
WPC icon
112
W.P. Carey
WPC
$15.6B
$399K 0.25%
+5,832
New +$477K
ALK icon
113
Alaska Air
ALK
$4.45B
$393K 0.25%
+10,050
New +$441K
WBA
114
DELISTED
Walgreens Boots Alliance
WBA
$387K 0.24%
12,315
-100
-0.8% -$3.71K
AZN icon
115
AstraZeneca
AZN
$251B
$376K 0.24%
3,425
– –
WY icon
116
Weyerhaeuser
WY
$16.1B
$372K 0.23%
13,040
+20
+0.2% +$681
NXPI icon
117
NXP Semiconductors
NXPI
$57.1B
$369K 0.23%
+2,500
New +$419K
HOLX
118
DELISTED
Hologic
HOLX
$355K 0.22%
5,500
– –
CNC icon
119
Centene
CNC
$33.4B
$354K 0.22%
4,550
-8,250
-64% -$737K
META icon
120
Meta Platforms (Facebook)
META
$1.71T
$352K 0.22%
2,591
-50
-2% -$8.1K
BEN icon
121
Franklin Templeton
BEN
$16.9B
$344K 0.22%
15,985
-900
-5% -$23.1K
CCI icon
122
Crown Castle
CCI
$31.2B
$340K 0.21%
+2,350
New +$402K
EMR icon
123
Emerson Electric
EMR
$82B
$338K 0.21%
4,623
+105
+2% +$8.72K
GNRC icon
124
Generac Holdings
GNRC
$10.3B
$338K 0.21%
+1,900
New +$436K
QSR icon
125
Restaurant Brands International
QSR
$26.3B
$322K 0.2%
6,049
– –
3 4
5
6 7

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q3 2022 Portfolio in Review

As of Q3 2022, New England Research & Management held 189 positions worth $159M, down 7.6% from $172M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2022 filing shows 40 new, 46 increased, 55 reduced and 32 closed positions. Its largest new stake was United Therapeutics: 5,550 shares worth $1.16M. The largest sale was Cheniere Energy, an estimated $2.66M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2022 buy was United Therapeutics: 5,550 shares worth $1.16M.
  • New England Research & Management added most to Coca-Cola in Q3 2022, an estimated $817K increase.
  • New England Research & Management's biggest Q3 2022 reduction was Walmart Inc, cutting an estimated $2.1M.
  • New England Research & Management fully exited Cheniere Energy in Q3 2022, selling an estimated $2.66M.
  • New England Research & Management's ten largest holdings make up 22% of its $159M portfolio in Q3 2022.
  • New England Research & Management opened 40 new positions and closed 32 in Q3 2022.
  • New England Research & Management's portfolio value fell 7.6% quarter-over-quarter to $159M.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.